Quantum Biopharma (QNTM) Loans and Notes Receivables (2022 - 2023)
Quantum Biopharma's (QNTM) quarterly Loans and Notes Receivables came in at $228536.0 in Q3 2023, up 104.97% year-on-year from $111498.7 in Q3 2022, and down 1.0% quarter-over-quarter from $230839.0 in Q2 2023.
Quantum Biopharma (QNTM) Loans and Notes Receivables (2022 - 2023) Analysis & Trends
Quantum Biopharma has disclosed Loans and Notes Receivables across 2 years of filings, most recently posting $228536.0 for Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans & Notes Receiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.60 Bn | 54.85 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 228,536.00 |
| Jun 30, 2023 | 230,839.00 |
| Mar 31, 2023 | 223,333.00 |
| Sep 30, 2022 | -4.60 Mn |
| Jun 30, 2022 | -2.39 Mn |